Updated:
Landos Biopharma, Inc.
Landos Biopharma, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001785345, and its reported industry...
Overview
Landos Biopharma, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001785345, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2024-03-21, it reported net income of USD -21,935,000; total assets of USD 38,040,000 for the fiscal period ended 2023-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Landos Biopharma, Inc.
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Blacksburg, VA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001785345
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2023USD | — | -$21.9M | $38.0M | $37.5M | -$20.5M | |
| FY2022USD | — | -$39.3M | $45.3M | $36.6M | -$45.8M | |
| FY2021USD | $18.0M | -$38.4M | $92.9M | $8.3M | -$27.1M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 10-K/A | 10-K/A | ||
| 8-K | 8-K | ||
| 10-K | 10-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 8-K | 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Landos Biopharma, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.